FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2009-01-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-008-1039-zPMID 19142633PMCID PMC2774795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease

  2008cited by this paper
• Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.

  2008cited by this paper
• Hippocampal hypometabolism predicts cognitive decline from normal aging.

  2008influential reference
• 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease

  2007cited by this paper
• Intraneuronal Aβ immunoreactivity is not a predictor of brain amyloidosis-β or neurofibrillary degeneration

  2007cited by this paper
• CO-PLANAR STEREOTAXIC ATLAS OF THE HUMAN BRAIN 3-DIMENSIONAL PROPORTIONAL SYSTEM: AN APPROACH TO CEREBRAL IMAGING 1988 GUIDE TO THE TNM/pTNM-CLASSIFICATION OF MALIGNANT TUMOURS THIRD EDITION

  2007cited by this paper
• Reduced hippocampal metabolism in MCI and AD

  2005cited by this paper
• Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004influential reference
• MCI conversion to dementia and the APOE genotype

  2004cited by this paper
• Mild cognitive impairment

  2003cited by this paper
• Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

  2003cited by this paper
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.

  2002cited by this paper
• Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET)

  2001influential reference
• Hippocampal formation glucose metabolism and volume losses in MCI and AD.

  2001cited by this paper
• Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

  2001cited by this paper
• Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

  2001cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999influential reference
• The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

  1999cited by this paper
• Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease

  1999cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

  1997influential reference
• Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis

  1996cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).

  1995influential reference
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• CT changes in dementing diseases.

  1987cited by this paper
• Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies.

  1986cited by this paper
• A new definition of Alzheimer's disease: a hippocampal dementia.

  1985cited by this paper
• Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• The Global Deterioration Scale for assessment of primary degenerative dementia.

  1982influential reference
• 共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値

  1980cited by this paper
• DIETARY FIBRE, TRANSIT-TIME, FÆCAL BACTERIA, STEROIDS, AND COLON CANCER IN TWO SCANDINAVIAN POPULATIONS Report from the International Agency for Research on Cancer Intestinal Microecology Group

  1977cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper
• Multi-infarct dementia. A cause of mental deterioration in the elderly.

  1974cited by this paper

• Hypoperfusion in early-phase amyloid PET as a predictor of cognitive decline in Alzheimer's disease.

  2026cites this paper
• The Impact of Ketogenic Diet Consumption on the Sporadic Alzheimer's Model Through MT1/MT2 Regulation

  2025cites this paper
• Fueling the brain - the role of apolipoprotein E in brain energy metabolism and its implications for Alzheimer’s disease

  2025cites this paper
• Clinical Use of Hypertonic Lactate - Current Evidence and Emerging Perspectives.

  2025cites this paper
• The rhythm of decline: Circadian disruption in neurodegeneration

  2025cites this paper
• Targeting Neurodegeneration with SGLT2is: From Molecular Mechanisms to Clinical Implications

  2025cites this paper
• Ceramides may Play a Central Role in the Pathogenesis of Alzheimer’s Disease: a Review of Evidence and Horizons for Discovery

  2025cites this paper
• Clinical Applications of PET Imaging in Alzheimer's Disease.

  2025cites this paper
• Diagnosis of Alzheimer’s disease using brain \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$^{18}\textrm{F}$$\end{doc

  2025cites this paper
• Decoding Blood-Brain Barrier Dysfunction in Alzheimer's Disease: Innovations and Challenges in Multimodal MRI and PET Imaging Biomarkers.

  2025cites this paper
• Cerebral phosphorus metabolite as imaging biomarkers in Alzheimer’s disease: a 31P magnetic resonance spectroscopy study

  2025cites this paper
• Longitudinal biomarker studies in human neuroimaging: capturing biological change of Alzheimer’s pathology

  2025cites this paper
• Prospective Assessment of Alzheimer's Disease-Like Hypometabolism Pattern in the Brain of Diabetics in Contrast to Non-diabetics on Positron Emission Tomography-Computed Tomography Images Using Fluorodeoxyglucose in India

  2025cites this paper
• Neural Metabolic Networks: Key Elements of Healthy Brain Function

  2025cites this paper
• Comparative Assessments of PET and ASL MR Perfusion in the Evaluation of Early Dementia

  2025cites this paper
• Energy metabolism in health and diseases

  2025cites this paper
• The Hippo signaling pathway as a therapeutic target in Alzheimer’s disease

  2025cites this paper
• Proteomic and metabolic profiling reveals APOE4-dependent shifts in whole brain, neuronal, and astrocytic mitochondrial function and glycolysis

  2025cites this paper
• Conditional Diffusion with Ordinal Regression: Longitudinal Data Generation for Neurodegenerative Disease Studies

  2025cites this paper
• Low-Dose Intranasal Metformin Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease

  2025cites this paper
• Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease

  2025cites this paper
• Exercise-Induced Neuroplasticity: Adaptive Mechanisms and Preventive Potential in Neurodegenerative Disorders

  2025cites this paper
• Basal forebrain activation improves working memory in senescent monkeys

  2025cites this paper
• Amyloid beta peptides inhibit glucose transport at the blood-brain barrier by disrupting the insulin-AKT pathway

  2025cites this paper
• Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions

  2025cites this paper
• Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease

  2025cites this paper
• Central cytometabolic functional vascular coupling in health and disease

  2025cites this paper
• Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research

  2025cites this paper
• Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis

  2024cites this paper
• Using the coefficient of determination to identify injury regions after stroke in pre-clinical FDG-PET images

  2024cites this paper
• Basal forebrain activation improves working memory in senescent monkeys

  2024influential citation
• PET/CT/MRI in Clinical Trials of Alzheimer’s Disease

  2024cites this paper
• Astrocytic Ca2+ activation by chemogenetics mitigates the effect of kainic acid‐induced excitotoxicity on the hippocampus

  2024cites this paper
• Advances in Blood Biomarkers for Alzheimer’s Disease: Ultra-Sensitive Detection Technologies and Impact on Clinical Diagnosis

  2024cites this paper
• The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia

  2024cites this paper
• Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease.

  2024cites this paper
• Use of biomarkers in the diagnosis of Alzheimer's disease in adults with intellectual disability.

  2024cites this paper
• High-Fat Diets in Animal Models of Alzheimer’s Disease: How Can Eating Too Much Fat Increase Alzheimer’s Disease Risk?

  2024cites this paper
• Mitochondria in Alzheimer’s Disease Pathogenesis

  2024cites this paper
• Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer’s Disease

  2024cites this paper
• Tensor Kernel Learning for Classification of Alzheimer’s Conditions using Multimodal Data

  2024cites this paper
• Redox imbalance and metabolic defects in the context of Alzheimer disease

  2024cites this paper
• An endophenotype network strategy uncovers YangXue QingNao Wan suppresses Aβ deposition, improves mitochondrial dysfunction and glucose metabolism.

  2024cites this paper
• Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature

  2024cites this paper
• Non-canonical Pathways Associated to Amyloid Beta and Tau Protein Dyshomeostasis in Alzheimer's disease: a narrative review.

  2024cites this paper
• An enquiry to the role of CB1 receptors in neurodegeneration.

  2023cites this paper
• FDG‐PET markers of heterogeneity and different risk of progression in amnestic MCI

  2023cites this paper
• Intranasal insulin - effects on the sense of smell.

  2023cites this paper
• Protocol Report on the Transcranial Photobiomodulation for Alzheimer’s Disease (TRAP-AD) Study

  2023cites this paper
• Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease

  2023cites this paper
• Partial Inhibition of Complex I Restores Mitochondrial Morphology and Mitochondria-ER Communication in Hippocampus of APP/PS1 Mice

  2023cites this paper
• Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients

  2023cites this paper
• Disturbed Level of Lactate Transporters in Brain Cells during Acute Toxic Effect of β-Amyloid In Vitro and In Vivo

  2023cites this paper
• Multimodal comparisons of QSM and PET in neurodegeneration and aging

  2023cites this paper
• Low glucose induced Alzheimer's disease‐like biochemical changes in human induced pluripotent stem cell‐derived neurons is due to dysregulated O‐GlcNAcylation

  2023cites this paper
• The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice

  2023cites this paper
• Systemic Growth Factor Increases as a Result of Exercise May Reduce Alzheimer's Disease Risk in Midlife Mice and Humans

  2023cites this paper
• Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease

  2023cites this paper
• Why Is Iron Deficiency/Anemia Linked to Alzheimer’s Disease and Its Comorbidities, and How Is It Prevented?

  2023cites this paper
• Disturbance in Expression of Lactate Transporters in Brain Cells under Acute Toxic Effect of Beta-Amyloid In Vitro and In Vivo

  2023cites this paper
• Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.

  2023cites this paper
• Recent progress of small-molecule-based theranostic agents in Alzheimer's disease.

  2023cites this paper
• Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary 18F-FDG PET/CT Study

  2023cites this paper
• Proteomic alterations in the brain and blood–brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer’s disease

  2023cites this paper
• Aging and Cerebral Glucose Metabolism: 18F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients

  2023cites this paper
• Banxia Xiexin Decoction Alleviated Cerebral Glucose Metabolism Disorder by Regulating Intestinal Microbiota in APP/PS1 Mice

  2023cites this paper
• Pharmacologic Enrichment of Exosome Yields and Mitochondrial Cargo.

  2022cites this paper
• Neuroimaging Modalities in Alzheimer’s Disease: Diagnosis and Clinical Features

  2022cites this paper
• Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRI

  2022cites this paper
• Metabolic hormones mediate cognition.

  2022cites this paper
• Brain Metabolic Alterations in Alzheimer’s Disease

  2022cites this paper
• The Implication of Physiological Ketosis on The Cognitive Brain: A Narrative Review

  2022cites this paper
• In vivo methods for imaging blood–brain barrier function and dysfunction

  2022cites this paper
• nEffects of ketogenic diet on cognitive functions of mice fed high-fat-high-cholesterol diet.

  2022cites this paper
• The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity

  2022cites this paper
• Amyloid Beta Peptides Inhibit Glucose Transport at the Blood-brain Barrier by Disrupting Insulin-Akt Pathway in Alzheimer’s Disease

  2022cites this paper
• Features of Cerebral Small Vessel Disease Contributes to the Differential Diagnosis of Alzheimer’s Disease

  2022cites this paper
• GLUT1 ablation in astrocytes paradoxically improves central and peripheral glucose metabolism via enhanced insulin-stimulated ATP release

  2022cites this paper
• A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau

  2022cites this paper
• Astrocytes as metabolic suppliers to support neuronal activity and brain functions

  2022cites this paper
• Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

  2022cites this paper
• Alzheimer’s Disease Prediction Using Attention Mechanism with Dual-Phase 18F-Florbetaben Images

  2022cites this paper
• Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions

  2022cites this paper
• Ketogenic dietary lifestyle intervention effects on sleep, cognition, and behavior in mild cognitive impairment: Study design

  2022cites this paper
• Residual reserve index modifies the effect of amyloid pathology on fluorodeoxyglucose metabolism: Implications for efficiency and capacity in cognitive reserve

  2022cites this paper
• Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention

  2022cites this paper
• Genotypic effects of APOE-ε4 on resting-state connectivity in cognitively intact individuals support functional brain compensation

  2022cites this paper
• Early alterations in brain glucose metabolism and vascular function in a transgenic rat model of Alzheimer's disease.

  2022cites this paper
• Lithium Enhances Hippocampal Glucose Metabolism in an In Vitro Mice Model of Alzheimer’s Disease

  2022cites this paper
• Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer’s disease continuum

  2022cites this paper
• GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

  2022cites this paper
• Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria

  2022cites this paper
• Exosome mediated Tom40 delivery protects against hydrogen peroxide-induced oxidative stress by regulating mitochondrial function

  2022cites this paper
• Effects of mobile phone electromagnetic radiation on rat hippocampus proteome

  2022cites this paper
• Latent feature representation learning for Alzheimer's disease classification

  2022cites this paper
• A High Fat/Cholesterol Diet Recapitulates Some Alzheimer’s Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction

  2021cites this paper
• The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.

  2021cites this paper
• A survey on functional and cognitive assessment for diagnosing neurodegenerative disorders

  2021cites this paper
• Alzheimer’s Disease Prediction Using Long Short-Term Memory with Early-Phase 18F-Florbetaben Imaging Data

  2021cites this paper
• A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease

  2021cites this paper